Actively Recruiting
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
Led by Dana-Farber Cancer Institute · Updated on 2025-06-03
40
Participants Needed
1
Research Sites
133 weeks
Total Duration
On this page
Sponsors
D
Dana-Farber Cancer Institute
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research study is to enhance inclusion and diversity in clinical trial enrollment by training participants to perform and provide feedback through a community-based protocol review process, called DIVERSE.
CONDITIONS
Official Title
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 or older
- English speaking
- Ability to understand and willing to provide oral consent
- Dana-Farber Cancer Institute patients in remission from blood cancer for more than 1 year are preferred
- Site or principal investigator who is not a member of the research team
You will not qualify if you...
- Adults unable to consent
- Individuals under 18 years old (infants, children, teenagers)
- Prisoners
- Unwilling or unable to maintain confidentiality of reviews and clinical trial materials
- Non-English speakers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
A
Andrew Hantel, MD
CONTACT
T
Thomas Walsh, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here